Detalhe da pesquisa
1.
Clinical factors associated with autologous stem cell transplantation outcomes in multiple myeloma: upfront transplant with MEL200 remains the standard of care.
Ann Hematol
; 103(1): 269-283, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-37880484
2.
Fixed-duration ibrutinib-venetoclax versus chlorambucil-obinutuzumab in previously untreated chronic lymphocytic leukaemia (GLOW): 4-year follow-up from a multicentre, open-label, randomised, phase 3 trial.
Lancet Oncol
; 24(12): 1423-1433, 2023 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-37944541
3.
Occurrence of familial Mediterranean fever in haemophilia patients.
Haemophilia
; 29(1): 165-171, 2023 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-36409293
4.
[Comparison of the Results of Galactomannan and Beta Glucan Antigen Tests in the Suspicion of Invasive Pulmonary Aspergillosis]. / Invaziv Pulmoner Aspergilloz Süpheli Hastalarda Galaktomannan ve Beta Glukan Antijen Testlerinin Karsilastirilmasi.
Mikrobiyol Bul
; 57(2): 274-282, 2023 Apr.
Artigo
em Turco
| MEDLINE | ID: mdl-37067211
5.
Isatuximab plus carfilzomib and dexamethasone versus carfilzomib and dexamethasone in elderly patients with relapsed multiple myeloma: IKEMA subgroup analysis.
Hematol Oncol
; 40(5): 1020-1029, 2022 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-35653225
6.
Comparison of daily oral iron replacement therapy with every other day treatment in female reproductive age patients with iron-deficiency anemia.
Ann Hematol
; 101(7): 1459-1464, 2022 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-35460388
7.
Is comprehensive geriatric testing guiding in the identification of multiple myeloma patients who are candidates for autologous stem cell transplantation? A prospective analysis.
Ann Hematol
; 101(12): 2691-2697, 2022 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-36195680
8.
Isatuximab plus carfilzomib and dexamethasone in relapsed multiple myeloma patients with high-risk cytogenetics: IKEMA subgroup analysis.
Eur J Haematol
; 109(5): 504-512, 2022 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-35871357
9.
Pomalidomide, bortezomib, and dexamethasone at first relapse in lenalidomide-pretreated myeloma: A subanalysis of OPTIMISMM by clinical characteristics.
Eur J Haematol
; 108(1): 73-83, 2022 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-34496096
10.
Long-term results of brentuximab vedotin in relapsed and refractory Hodgkin lymphoma: multi-center real-life experience.
Ann Hematol
; 99(2): 301-307, 2020 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-31844933
11.
Early Prognostic Value of Monitoring Serum Free Light Chain in Patients with Multiple Myeloma Undergoing Autologous Stem Cell Transplantation.
Cancer Invest
; 35(3): 195-201, 2017 Mar 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-28112977
12.
Effects of Rat Bone Marrow-Derived Mesenchymal Stem Cells and Demineralized Bone Matrix on Cranial Bone Healing.
Ann Plast Surg
; 77(2): 249-54, 2016 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-27070677
13.
Prevalence of monoclonal B lymphocytosis in first-degree relatives of chronic lymphocytic leukemia patients in Turkey.
Turk J Haematol
; 32(1): 29-34, 2015 Mar 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-25805672
14.
Pomalidomide, Bortezomib, and Dexamethasone in Lenalidomide-Pretreated Multiple Myeloma: A Subanalysis of OPTIMISMM by Frailty and Bortezomib Dose Adjustment.
Clin Lymphoma Myeloma Leuk
; 24(3): 165-176.e4, 2024 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-38072743
15.
Tumor-associated macrophages as a prognostic parameter in multiple myeloma.
Ann Hematol
; 92(5): 669-77, 2013 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-23334187
16.
HBV-related events after allogeneic hematopoetic stem cell transplantation in a center from Turkey.
Ann Hematol
; 92(3): 395-402, 2013 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-23143119
17.
Hyper-CVAD regimen in routine management of adult acute lymphoblastic leukemia: a retrospective multicenter study.
Acta Haematol
; 130(3): 199-205, 2013.
Artigo
em Inglês
| MEDLINE | ID: mdl-23797290
18.
Is flow cytometry useful in determining central nervous system involvement in patients with hematological malignancy? Analysis with a prospective cohort.
Leuk Res
; 131: 107332, 2023 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-37307678
19.
Preconditioning Modified-Easix as a Predictor of Prognosis in Allogeneic Hematopoietic Stem Cell Transplant Recipients.
Indian J Hematol Blood Transfus
; 39(4): 586-597, 2023 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-37786821
20.
Long-term Results of Imatinib Discontinuation in Patients with Chronic-phase Chronic Myeloid Leukemia: A National Multicenter Prospective Study
Turk J Haematol
; 40(4): 236-241, 2023 12 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-37877113